The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect
| dc.contributor.author | Rasmi, Yousef | |
| dc.contributor.author | Jalali, Ladan | |
| dc.contributor.author | Khalid, Saliha | |
| dc.contributor.author | Shokati, Ameneh | |
| dc.contributor.author | Tyagi, Poonam | |
| dc.contributor.author | Ozturk, Alpaslan | |
| dc.contributor.author | Nasimfar, Amir | |
| dc.date.accessioned | 2023-10-19T15:11:32Z | |
| dc.date.available | 2023-10-19T15:11:32Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | Prolactin (PRL) is an endocrine hormone secreted by the anterior pituitary gland that has a variety of physiological effects, including milk production, immune system regulation, and anti-inflammatory effects. Elevated levels of PRL have been found in several viral infections, including 2019 coronavirus disease (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), a viral pathogen that has recently spread worldwide. PRL production is increased in SARS-CoV2 infection. While PRL can trigger the production of proinflammatory cytokines, it also has several anti-inflammatory effects that can reduce hyperinflammation. The exact mechanism of PRL's contribution to the severity of COVID-19 is unknown. The purpose of this review is to discuss the interaction between PRL and SARS-CoV2 infection and its possible association with the severity of COVID-19. | en_US |
| dc.identifier.doi | 10.1016/j.cyto.2023.156253 | en_US |
| dc.identifier.issn | 1043-4666 | |
| dc.identifier.issn | 1096-0023 | |
| dc.identifier.scopus | 2-s2.0-85162171729 | en_US |
| dc.identifier.uri | https://doi.org/10.1016/j.cyto.2023.156253 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.12469/5061 | |
| dc.language.iso | en | en_US |
| dc.publisher | Academic Press Ltd- Elsevier Science Ltd | en_US |
| dc.relation.ispartof | Cytokine | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | Necrosis-Factor-Alpha | En_Us |
| dc.subject | Activated Macrophages | En_Us |
| dc.subject | Signal-Transduction | En_Us |
| dc.subject | Growth-Hormone | En_Us |
| dc.subject | C-Jun | En_Us |
| dc.subject | Expression | En_Us |
| dc.subject | Cell | En_Us |
| dc.subject | Receptor | En_Us |
| dc.subject | Mechanisms | En_Us |
| dc.subject | Release | En_Us |
| dc.subject | Necrosis-Factor-Alpha | |
| dc.subject | Activated Macrophages | |
| dc.subject | Signal-Transduction | |
| dc.subject | Growth-Hormone | |
| dc.subject | C-Jun | |
| dc.subject | Expression | |
| dc.subject | Prolactin | en_US |
| dc.subject | Cell | |
| dc.subject | SARS-CoV-2 | en_US |
| dc.subject | Receptor | |
| dc.subject | Severity | en_US |
| dc.subject | Mechanisms | |
| dc.subject | COVID-19 | en_US |
| dc.subject | Release | |
| dc.subject | Immunomodulatory effects | en_US |
| dc.title | The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect | en_US |
| dc.type | Article | en_US |
| dspace.entity.type | Publication | |
| gdc.bip.impulseclass | C4 | |
| gdc.bip.influenceclass | C5 | |
| gdc.bip.popularityclass | C4 | |
| gdc.coar.access | metadata only access | |
| gdc.coar.type | text::journal::journal article | |
| gdc.collaboration.industrial | false | |
| gdc.description.departmenttemp | [Rasmi, Yousef; Jalali, Ladan] Urmia Univ Med Sci, Fac Med, Dept Biochem, Orumiyeh, Iran; [Khalid, Saliha] Kadir Has Univ, Sch Engn & Nat Sci, Dept Bioinformat & Genet, Cibali Campus Fatih, TR-34083 Istanbul, Turkiye; [Shokati, Ameneh] Univ Tehran Med Sci, Sch Adv Technol Med, Dept Appl Cell Sci, Tehran, Iran; [Shokati, Ameneh] Univ Tehran Med Sci, Neurosci Inst, Multiple Sclerosis Res Ctr, Tehran, Iran; [Tyagi, Poonam] Prince Sattam Bin Abdulaziz Univ, Coll Appl Med Sci, Dept Clin Lab Sci, Riyadh, Saudi Arabia; [Ozturk, Alpaslan] Hlth Sci Univ, Ankara Diskapi Yildirim Beyazit Training & Res Hos, Dept Med Biochem, Ankara, Turkiye; [Nasimfar, Amir] Urmia Univ Med Sci, Fac Med, Dept Pediat, Orumiyeh, Iran; [Jalali, Ladan] Urmia Univ Med Sci, Sch Med, Dept Biochem, Orumiyeh, Iran | en_US |
| gdc.description.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
| gdc.description.scopusquality | Q2 | |
| gdc.description.startpage | 156253 | |
| gdc.description.volume | 169 | en_US |
| gdc.description.wosquality | Q2 | |
| gdc.identifier.openalex | W4379743204 | |
| gdc.identifier.pmid | 37320963 | en_US |
| gdc.identifier.wos | WOS:001054021200001 | en_US |
| gdc.index.type | WoS | |
| gdc.index.type | Scopus | |
| gdc.index.type | PubMed | |
| gdc.oaire.diamondjournal | false | |
| gdc.oaire.impulse | 22.0 | |
| gdc.oaire.influence | 3.086183E-9 | |
| gdc.oaire.isgreen | true | |
| gdc.oaire.keywords | Immunomodulatory effects | |
| gdc.oaire.keywords | Signal-Transduction | |
| gdc.oaire.keywords | C-Jun | |
| gdc.oaire.keywords | SARS-CoV-2 | |
| gdc.oaire.keywords | Anti-Inflammatory Agents | |
| gdc.oaire.keywords | COVID-19 | |
| gdc.oaire.keywords | Expression | |
| gdc.oaire.keywords | Severity | |
| gdc.oaire.keywords | Article | |
| gdc.oaire.keywords | Prolactin | |
| gdc.oaire.keywords | Activated Macrophages | |
| gdc.oaire.keywords | Release | |
| gdc.oaire.keywords | Immune System | |
| gdc.oaire.keywords | Growth-Hormone | |
| gdc.oaire.keywords | Mechanisms | |
| gdc.oaire.keywords | Necrosis-Factor-Alpha | |
| gdc.oaire.keywords | Humans | |
| gdc.oaire.keywords | RNA, Viral | |
| gdc.oaire.keywords | Cell | |
| gdc.oaire.keywords | Receptor | |
| gdc.oaire.popularity | 1.853236E-8 | |
| gdc.oaire.publicfunded | false | |
| gdc.openalex.collaboration | International | |
| gdc.openalex.fwci | 8.40946942 | |
| gdc.openalex.normalizedpercentile | 0.96 | |
| gdc.openalex.toppercent | TOP 10% | |
| gdc.opencitations.count | 10 | |
| gdc.plumx.crossrefcites | 1 | |
| gdc.plumx.facebookshareslikecount | 20 | |
| gdc.plumx.mendeley | 36 | |
| gdc.plumx.newscount | 1 | |
| gdc.plumx.pubmedcites | 9 | |
| gdc.plumx.scopuscites | 19 | |
| gdc.scopus.citedcount | 19 | |
| gdc.wos.citedcount | 18 | |
| relation.isOrgUnitOfPublication | b20623fc-1264-4244-9847-a4729ca7508c | |
| relation.isOrgUnitOfPublication.latestForDiscovery | b20623fc-1264-4244-9847-a4729ca7508c |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- 5061.pdf
- Size:
- 769.11 KB
- Format:
- Adobe Portable Document Format
- Description:
- Tam Metin / Full Text
